| Mrs Nannette Luneau Chenevert, LCSW | |
|
242 West Shamrock Unit 1, Pineville, LA 71360 | |
| (318) 484-6850 | |
| (318) 484-6844 |
| Full Name | Mrs Nannette Luneau Chenevert |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 33 Years |
| Location | 242 West Shamrock Unit 1, Pineville, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447497722 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4142 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central La Human Services District | 7618105529 | 20 |
News Archive
RepRegen™, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that three-month data from an in vivo study of its StronBone™ bioactive glass with Strontium demonstrated that it can generate bone quality in and around defects that appears by analytical tests to be significantly superior to a standard bone void filler in the control defect.
The Food Standards Agency in the UK is recommending the addition of the vitamin folic acid to all flour and bread on sale in Britain within the next year.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Researchers at Rensselaer Polytechnic Institute and University of North Carolina at Chapel Hill have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from clotting.
› Verified 3 days ago
| Entity Name | Central La Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033543756 PECOS PAC ID: 7618105529 Enrollment ID: O20140122000223 |
News Archive
RepRegen™, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that three-month data from an in vivo study of its StronBone™ bioactive glass with Strontium demonstrated that it can generate bone quality in and around defects that appears by analytical tests to be significantly superior to a standard bone void filler in the control defect.
The Food Standards Agency in the UK is recommending the addition of the vitamin folic acid to all flour and bread on sale in Britain within the next year.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Researchers at Rensselaer Polytechnic Institute and University of North Carolina at Chapel Hill have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from clotting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nannette Luneau Chenevert, LCSW 242 West Shamrock Unit 1, Pineville, LA 71360 Ph: (318) 484-6850 | Mrs Nannette Luneau Chenevert, LCSW 242 West Shamrock Unit 1, Pineville, LA 71360 Ph: (318) 484-6850 |
News Archive
RepRegen™, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that three-month data from an in vivo study of its StronBone™ bioactive glass with Strontium demonstrated that it can generate bone quality in and around defects that appears by analytical tests to be significantly superior to a standard bone void filler in the control defect.
The Food Standards Agency in the UK is recommending the addition of the vitamin folic acid to all flour and bread on sale in Britain within the next year.
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Researchers at Rensselaer Polytechnic Institute and University of North Carolina at Chapel Hill have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from clotting.
› Verified 3 days ago
Mrs. Donna G Mccrary, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010 Fax: 318-483-5036 | |
Mr. Michael Roach, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010 | |
Mrs. Dana Carrington, MSW,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Hazmuka Rd, Pineville, LA 71360 Phone: 318-473-0010 | |
Rakinzie Monique Fisher-denham, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Alexandria Va Health Care System, 2495 Shreveport Highway, Pineville, LA 71360 Phone: 318-623-0663 | |
Mrs. Megan Guillory Williams, MSW-LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-466-4186 | |
Mrs. Jill Scheppf, MSW, LCSW-BACS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy # 71, Pineville, LA 71360 Phone: 318-466-2059 | |
Mr. Todd Mason Renegar, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy, Pineville, LA 71360 Phone: 318-473-0010 |